[1]徐红梅,高立明.血清白细胞介素-6、白细胞介素-12、白细胞介素-17水平与胃癌化疗患者预后关系研究[J].陕西医学杂志,2024,(10):1377-1380,1386.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.017]
　XU Hongmei,GAO Liming.Relationship between serum IL-6,IL-12,IL-17 levels and prognosis in gastric cancer patients undergoing chemotherapy[J].,2024,(10):1377-1380,1386.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.017]
点击复制

血清白细胞介素-6、白细胞介素-12、白细胞介素-17水平与胃癌化疗患者预后关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1377-1380,1386
栏目:
临床研究
出版日期:
2024-10-05

文章信息/Info

Title:
Relationship between serum IL-6,IL-12,IL-17 levels and prognosis in gastric cancer patients undergoing chemotherapy
作者:
徐红梅; 高立明
(秦皇岛市第一医院肿瘤科,河北 秦皇岛 066000)
Author(s):
XU Hongmei; GAO Liming
(Department of Oncology,First Hospital of Qinhuangdao,Qinhuangdao 066000,China)
关键词:
胃癌;  化疗;  预后;  白细胞介素-6;  白细胞介素-12;  白细胞介素-17
Keywords:
Gastric cancer;  Chemotherapy;  Prognosis;  Interleukin-6;  Interleukin-12;  Interleukin-17
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.10.017
文献标志码:
A
摘要:
目的:分析血清白细胞介素(IL)-6、IL-12、IL-17水平与胃癌化疗患者预后的关系。方法:收集109例接受化疗干预的胃癌患者临床资料,根据患者的预后情况将其分为预后良好组(n=68)与预后不良组(n=41)。记录并统计患者临床资料,经Pearson相关性分析血清IL-6、IL-12、IL-17水平与胃癌患者化疗预后的关系; 经Logistic回归分析探讨影响胃癌化疗预后的影响因素; 经受试者工作特征(ROC)曲线分析血清IL-6、IL-12、IL-17水平对胃癌患者化疗预后的预测价值。结果:预后不良组年龄及血清IL-6、IL-17水平均较预后良好组高,而IL-12水平较预后良好组低(均P<0.05); 经Pearson相关性分析显示,血清IL-6、IL-17水平均与胃癌化疗患者不良预后呈正相关,血清IL-12水平与胃癌化疗患者不良预后呈负相关(均P<0.05); 经Logistic回归分析显示,血清IL-6、IL-17水平异常升高均为影响胃癌化疗预后的独立危险因素,而血清IL-12水平升高为影响胃癌化疗预后的保护因素(均P<0.05); 经ROC曲线分析显示,血清IL-6、IL-12、IL-17水平均对胃癌化疗预后具有较好预测价值,其中以血清IL-17的预测价值相对最好(均P<0.05)。结论:胃癌化疗患者血清IL-6、IL-17水平越高,IL-12水平越低,其不良预后发生风险也相对越高,通过监测上述指标水平有利于早期辅助临床预测患者预后情况。
Abstract:
Objective:To analyze the relationship between serum interleukin-6(IL-6),IL-12,IL-17 levels and the prognosis in gastric cancer patients undergoing chemotherapy.Methods:The clinical data of 109 gastric cancer patients who underwent chemotherapy were collected retrospectively.Based on the prognosis,patients included were divided into good prognosis group(68 cases)and poor prognosis group(41 cases).The clinical data of the patients were recorded and analyzed.Pearson correlation analysis was performed to discuss the relationship between serum IL-6,IL-12 and IL-17 levels and the prognosis in gastric cancer patients undergoing chemotherapy.Logistic regression analysis was performed to screen the factors influencing the prognosis of chemotherapy for gastric cancer.ROC curves were used to analyze the prognostic value of serum IL-6,IL-12 and IL-17 levels in gastric cancer patients undergoing chemotherapy.Results:Age and serum IL-6 and IL-17 levels of the poor prognosis group were higher than those of the good prognosis group.IL-12 levels were lower than those of the good prognosis group(all P<0.05).Pearson correlation analysis found that serum IL-6 and IL-17 levels were positively correlated with poor prognosis,while serum IL-12 level was negatively correlated with poor prognosis in gastric cancer patients undergoing chemotherapy(all P<0.05).Logistic regression analysis results showed that abnormally elevated serum IL-6 and IL-17 levels were independent risk factors affecting the prognosis of chemotherapy for gastric cancer,while elevated serum IL-12 level was a protective factor(all P<0.05).ROC curves indicated that serum IL-6,IL-12 and IL-17 level were helpful for predicting the prognosis of chemotherapy for gastric cancer,and the performance of serum IL-17 was the best(all P<0.05).Conclusion:The higher the serum IL-6 and IL-17 levels,the lower the level of IL-12,the higher the risk of poor prognosis in gastric cancer patients undergoing chemotherapy.Monitoring the levels of these indicators is beneficial for early clinical prediction of prognosis.

参考文献/References:

[1] 李向阳,任磊,梁瑞.血清基质金属蛋白酶-9,基质金属蛋白酶-2水平对胃癌腹膜转移及预后的预测价值[J].陕西医学杂志,2023,52(2):166-170.
[2] 孟肖,张新庆,李璐,等.培元益气汤改善气阴两虚证胃癌相关癌性疲乏及对患者免疫功能的影响[J].陕西中医,2023,44(2):174-177.
[3] 李沛霖,邓莉莹,岳月娟,等.加速康复外科理念结合健康教育对老年胃癌手术患者出院准备度及生活质量的影响[J].中国老年学杂志,2022,42(12):2909-2912.
[4] 张佩,余明红,何丽波,等.胃癌化疗患者中医体质分型与化疗期间感染和免疫功能及胃肠道菌群的关系[J].中华医院感染学杂志,2023,33(3):386-390.
[5] 曹爽,吴亚,朱颉,等.健脾养胃方联合化疗对胃癌患者T细胞亚群,凝血标志物的影响[J].中国现代医学杂志,2023,33(19):24-29.
[6] 华科雷,霍明科,董志闯,等.外周血小板淋巴细胞比值变化在新辅助化疗胃癌患者预后中的价值[J].中华医学杂志,2022,102(12):858-863.
[7] 吴东,张庆红,胡兆雄,等.miR-450b-3p/TLR8轴在RSV感染肾细胞后对细胞因子IL-6,IL-10,IL-17和IFN-γ分泌的研究[J].免疫学杂志,2022,38(12):1046-1053.
[8] 申鑫鑫,豆贝贝,滑天,等.高危型HPV16感染阴道灌洗液中TNF-α及IL-12和IL-10表达与宫颈上皮内瘤变级别的相关性[J].中华医院感染学杂志,2021,31(9):1419-1422.
[9] 马蓉,张新爱,杨洋,等.腺苷酸环化酶相关蛋白2,纤维连接蛋白1表达与胃癌病理类型及预后关系探讨[J].陕西医学杂志,2021,50(2):241-244.
[10] 杨红斌,王甜甜,张欣.养正散结汤联合放化疗治疗胃癌根治术后腹腔淋巴结转移癌临床研究[J].陕西中医,2021,42(11):1544-1548.
[11] 孙婧悦,王啸,王振欣,等.血清外泌体miRNAs在晚期胃癌患者化疗疗效预测中的价值[J].中国肿瘤临床,2022,49(4):174-178.
[12] 卜珊珊,王俊杰,王婷,等.术前和术后同步放化疗在Ⅲ-ⅣA期胃癌的疗效及安全性比较[J].中华放射医学与防护杂志,2022,42(5):367-372.
[13] 田春方,井海燕,王潍博,等.374例根治术后肠型胃癌患者预后的影响因素分析[J].中国肿瘤临床,2021,48(11):559-565.
[14] 李玉娟.学龄期难治性肺炎支原体肺炎临床特点及危险因素分析[J].感染?炎症?修复,2021,22(1):24-29.
[15] 张洁,梁平,李建波,等.青蒿鳖甲汤加减治疗癌性发热疗效及对NF-κB p65蛋白,IL-6,IL-10,TNF-α的影响[J].中华中医药学刊,2023,41(5):220-223.
[16] 李玮柏,曹娟,郭秀,等.肿瘤相关巨噬细胞来源IL-6通过上调肿瘤细胞中LIF表达对口腔鳞状细胞癌Cal27细胞侵袭和迁移的促进作用[J].吉林大学学报:医学版,2022,48(4):946-953.
[17] 刘敏,陈添亮,郭娟,等.蛋白激酶CβⅡ通过IL-6自分泌途径促进肝细胞癌侵袭的研究[J].中国癌症杂志,2021,31(4):268-276.
[18] 王茹,钟桂兰,王小花,等.SOCS3介导IL-6/STAT3通路在卵巢上皮癌细胞增殖凋亡过程中的作用机制[J].中国老年学杂志,2022,42(23):5753-5757.
[19] 韦伊尔,冼乐武,田艳,等.lncRNA SNHG1调控miR-5195-3p抑制IL-6诱导的胃癌细胞增殖和转移[J].中国免疫学杂志,2023,39(3):550-554.
[20] 得丽扎尔?热合曼,卡得了亚?哈依沙尔,王中香,等.携带HPV16 E7 shRNA和IL-12基因的重组短双歧杆菌抗小鼠宫颈癌移植瘤的疗效和安全性[J].中国肿瘤生物治疗杂志,2022,29(4):301-307.
[21] 黄京华,金东春,韩亨敏,等.IL-12调控胃癌细胞凋亡及免疫逃逸因子分泌机制探讨[J].中华肿瘤防治杂志,2021,28(3):178-183.
[22] 孟盼,韩远山,罗薇絮,等.基于IL-6/GP130信号研究逍遥抗癌解郁方调节乳腺癌并发抑郁症模型小鼠肿瘤、海马组织免疫的机制[J].中国中医基础医学杂志,2023,29(7):1091-1095.
[23] 谭真,邱晓丽,孙建.miR-612通过调控TMPRSS4表达抑制IL-17对胃癌细胞增殖,迁移,侵袭的机制[J].中国老年学杂志,2021,41(24):5722-5727.
[24] 宋杨,杨见明.IL-17及其受体调控DLL4-Notch信号通路影响甲状腺乳头状癌新生血管生成[J].安徽医科大学学报,2023,58(7):1146-1152.
[25] 袁靖.老年弥漫大B细胞淋巴瘤患者血清VEGF和IL-17水平变化[J].中国老年学杂志,2022,42(22):5460-5463.

相似文献/References:

[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
　HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(10):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
　TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(10):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
　LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(10):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
　MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(10):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
　SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(10):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
　GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(10):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
　KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(10):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
　LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(10):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
[11]李润媛,黄于庭.胃癌患者化疗前后血管内皮生长因子动态变化与临床获益关系研究[J].陕西医学杂志,2023,52(8):1042.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.023]

备注/Memo

备注/Memo:
基金项目:河北省秦皇岛市科学技术研究与发展计划项目(202301A183)
更新日期/Last Update: 2024-10-08